Clorox (NYSE:CLX) Price Target Raised to $155.00 at Evercore ISI

Clorox (NYSE:CLX) had its price target lifted by Evercore ISI from $145.00 to $155.00 in a research note issued on Tuesday. Evercore ISI’s price target would suggest a potential upside of 2.41% from the stock’s previous close.

Other research analysts also recently issued research reports about the company. TD Cowen raised Clorox from a “sell” rating to a “hold” rating and increased their price target for the company from $155.00 to $170.00 in a research note on Wednesday, November 6th. Barclays cut their price target on Clorox from $139.00 to $130.00 and set an “underweight” rating on the stock in a research note on Friday, January 17th. DA Davidson increased their price target on Clorox from $153.00 to $171.00 and gave the company a “neutral” rating in a research note on Monday, November 4th. Wells Fargo & Company increased their price target on Clorox from $157.00 to $161.00 and gave the company an “equal weight” rating in a research note on Tuesday. Finally, JPMorgan Chase & Co. increased their price target on Clorox from $171.00 to $173.00 and gave the company a “neutral” rating in a research note on Tuesday. Four equities research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and one has given a buy rating to the stock. According to MarketBeat.com, Clorox currently has an average rating of “Hold” and a consensus price target of $157.64.

Clorox Trading Down 5.3 %

NYSE:CLX traded down $8.42 during trading hours on Tuesday, hitting $151.36. 1,377,391 shares of the stock were exchanged, compared to its average volume of 1,142,576. The company’s 50 day moving average is $162.76 and its two-hundred day moving average is $158.50. Clorox has a twelve month low of $127.60 and a twelve month high of $171.37. The company has a quick ratio of 0.62, a current ratio of 1.00 and a debt-to-equity ratio of 11.08. The company has a market capitalization of $18.74 billion, a P/E ratio of 52.68, a price-to-earnings-growth ratio of 2.92 and a beta of 0.42.

Clorox (NYSE:CLX) last posted its quarterly earnings data on Monday, February 3rd. The company reported $1.55 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.39 by $0.16. Clorox had a return on equity of 316.08% and a net margin of 4.78%. During the same quarter in the prior year, the business posted $2.16 EPS. On average, sell-side analysts anticipate that Clorox will post 6.86 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Clorox

A number of large investors have recently added to or reduced their stakes in CLX. Czech National Bank increased its holdings in Clorox by 6.6% during the 3rd quarter. Czech National Bank now owns 25,232 shares of the company’s stock worth $4,111,000 after purchasing an additional 1,567 shares in the last quarter. GAMMA Investing LLC increased its holdings in Clorox by 63.0% during the 3rd quarter. GAMMA Investing LLC now owns 1,795 shares of the company’s stock worth $292,000 after purchasing an additional 694 shares in the last quarter. New England Research & Management Inc. bought a new position in Clorox during the 3rd quarter worth about $216,000. Affinity Capital Advisors LLC bought a new position in shares of Clorox in the 3rd quarter valued at about $224,000. Finally, Axiom Advisory LLC grew its holdings in shares of Clorox by 1.6% in the 3rd quarter. Axiom Advisory LLC now owns 11,328 shares of the company’s stock valued at $1,679,000 after acquiring an additional 177 shares in the last quarter. Institutional investors own 78.53% of the company’s stock.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.